SEC 13F Intelligence

Abrams Capital Management, L.P. / NUVB

Abrams Capital Management, L.P.’s Nuvation Bio Inc Position

Does Abrams Capital Management, L.P. own Nuvation Bio Inc (NUVB)? Yes — 1.27M shares worth $5M (+0.12% of its 13F portfolio) as of Q1 2026, down from 3.81M shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
1.27M
% of Portfolio
+0.12%
Quarters Held
21
currently held

Position History NUVB

Reported value by quarter
Q1 ’21: $34MQ1 ’21Q2 ’21: $35MQ3 ’21: $38MQ4 ’21: $32MQ4 ’21Q1 ’22: $20MQ2 ’22: $12MQ3 ’22: $9MQ3 ’22Q4 ’22: $7MQ1 ’23: $6MQ2 ’23: $7MQ2 ’23Q3 ’23: $5MQ4 ’23: $6MQ1 ’24: $14MQ1 ’24Q2 ’24: $11MQ3 ’24: $9MQ4 ’24: $10MQ4 ’24Q1 ’25: $7MQ2 ’25: $7MQ3 ’25: $14MQ3 ’25Q4 ’25: $34MQ1 ’26: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.27M$5M+0.12%
Q4 20253.81M$34M+0.60%
Q3 20253.81M$14M+0.23%
Q2 20253.81M$7M+0.12%
Q1 20253.81M$7M+0.12%
Q4 20243.81M$10M+0.16%
Q3 20243.81M$9M+0.14%
Q2 20243.81M$11M+0.22%
Q1 20243.81M$14M+0.43%
Q4 20233.81M$6M+0.18%
Q3 20233.81M$5M+0.17%
Q2 20233.81M$7M+0.20%
Q1 20233.81M$6M+0.20%
Q4 20223.81M$7M+0.26%
Q3 20223.81M$9M+0.25%
Q2 20223.81M$12M+0.33%
Q1 20223.81M$20M+0.47%
Q4 20213.81M$32M+0.71%
Q3 20213.81M$38M+0.83%
Q2 20213.81M$35M+0.79%
Q1 20213.81M$34M+0.77%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abrams Capital Management, L.P.’s full portfolio or all institutional holders of NUVB.